Symmetry Surgical Announces 2015 Financial Guidance

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Symmetry Surgical Announces 2015 Financial Guidance

Expects 2015 Revenue of $77-$84 Million

Expects 2015 EBITDA of $6.2-$8.0 Million

NASHVILLE, Tenn., Jan. 9, 2015 (GLOBE NEWSWIRE) -- Symmetry Surgical Inc. (Nasdaq: SSRG ) announced today revenue and EBITDA guidance for 2015. The following forward-looking estimates regarding 2015 guidance reflect current market conditions and foreign currency rates. Actual results may differ materially, and the Company refers you to forward-looking statements located at the end of the press release. For the full year 2015, the Company expects revenue to be in the range of $77 to $84 million. The Company expects full year 2015 EBITDA to be in the range of $6.2 to $8.0 million.

Thomas J. Sullivan, Symmetry Surgical's President and Chief Executive Officer, said, "In 2015, despite the expected ongoing sluggish hospital spending environment, our goal is to achieve year-over-year revenue growth and stronger EBITDA increases. Our growth will be driven by improved execution in our existing business and new product launches, as well as upside potential from the recent neoSurgical distribution agreement. We also expect to generate solid free cash flow, which will enable us to further invest in our growth strategies."

Mr. Sullivan added, "In the fourth quarter of 2014, our primary focus was the creation of a standalone Symmetry Surgical business, which we achieved on December 5th. Since that time, we have begun implementation of several initiatives to position the business for improved revenue growth, which I look forward to outlining over the coming year. While we still have work to do, we expect our fourth quarter results to reflect continued progress against the backdrop of a constrained hospital spending environment in the U.S. and Europe."

The Company's fiscal year ends on the Saturday closest to December 31, which resulted in the inclusion of a 53 rd week in fiscal year 2014 and a 14 th week in the fiscal fourth quarter 2014. Due to the timing of the year-end holiday, the Company believes that the effect of the additional week on sales for the quarter was somewhat minimized. Preliminary, unaudited revenue for the fourth quarter 2014 is expected to be in the range of $20.0 to $20.4 million. For the full year 2014, reported revenue is expected to be in the range of $81.5 to $81.9 million, which includes $2.7 million of revenue related to the New Wave Surgical product line, which was acquired by a third party in the first quarter and no longer sold by Symmetry Surgical after April 30, 2014. Excluding the impact of the loss of the New Wave Surgical product line, full year 2014 revenue is expected to be in the range of $78.8 to $79.2 million.

The financial estimates presented above are preliminary and remain subject to management's final review and audit by the Company's independent registered accounting firm. The Company intends to report complete fourth quarter and full year 2014 financial results in February. Details regarding the timing of the release of those results, as well as details of a conference call and publicly available webcast, will be announced in a subsequent press release.

About Symmetry Surgical Inc.

Symmetry Surgical is dedicated to developing and delivering high-quality, innovative surgical instruments that meet clinicians' needs and improve patients' lives. Our team collaborates with healthcare providers around the world to provide medical devices that exceed our customers' expectations and provide solutions for today's needs and tomorrow's growth. Our rich and diverse history creates one of the industry's most comprehensive surgical instrument portfolios, which includes our well-known brands such as BOOKWALTER ® , GREENBERG ® , RILEY ™ , OLSEN ™ , ULTRA ™ , QUAD-LOCK ® , FLASHPAK ® , RAPIDCLEAN ® , OPTI-LENGTH ® , CLASSIC ® and CLASSIC PLUS ® . Symmetry Surgical is headquartered in Nashville, TN. For more information, please visit www.symmetrysurgical.com .

Forward-Looking Statement

This press release includes statements that express our opinions, expectations, beliefs, plans, objectives and assumptions regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements." These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "expects," "may," "will," "should," "seeks," "projects," "approximately," "intends," "plans," "estimates" or "anticipates," or, in each case, their negatives or other variations or comparable terminology. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future, including risks and uncertainties relating to performance or outcomes which could differ materially from our current expectations. Unless required by applicable law, Symmetry Surgical undertakes no obligation to update or revise any such forward-looking statements whether as a result of new information, future events or otherwise. We refer you to the "Risk Factors" section in the Company's Form S-4 Registration Statement filed with the Securities and Exchange Commission on October 31, 2014, and the amendments related to it, as well as the Company's other filings, all of which are available on the SEC's Web site at www.sec.gov .

Investor Contact: Zack Kubow The Ruth Group 646-536-7020 Media Contact: Calvin Allen The Ruth Group 646-536-7002

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 45

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Monotype Unveils Font Tool for Adobe: A Game-Changer?

Updated Category News Views 106

Monotype Connect: Fonts Meet Convenience Imagine fighting through a blizzard with a flashlight. That's how designers juggle fonts without a central tool. Well, Monotype's got them covered with the new Connect panel for Adobe apps—a beacon of efficiency spotted at Adobe MAX 2026 in Miami Beach. Efficiency and Brand Unity: Partners in Design Now, here’s why this isn’t...

Continue Reading
Home Energy Tips: Embrace the Electrical Panel Shift

Updated Category News Views 52

Why Electrical Panels Matter More Than Ever Back in the day, electrical panels weren't exactly the star of the homeowner show. But times have changed, and those previously mundane boxes of switches and wires now demand a spotlight. Shifts in modern lifestyles have catapulted electrical systems into the spotlight, making upgrades a pressing conversation topic for savvy...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Panasonic Showcases Rugged Tech at NATO Edge 26

Updated Category News Views 56

Panasonic Heads to Turkey with Tactical Tech Panasonic's got its sights set on proving a point at NATO Edge 26, busting out its TOUGHBOOK line and showing just how these rugged laptops aren't just tough, but also strategically essential. From November 17th through 19th, down in Turkey, these devices are taking the spotlight as they embrace the operational challenges of...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 111

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 77

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 148

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 45

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 83

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading

Top 5 Most Recently Viewed Articles

Tevogen Bio Achieves Nasdaq Compliance and Future Prospects

Updated Category News Views 107

Tevogen Bio Regains Compliance with Nasdaq Listing Standards Tevogen Bio Holdings Inc. (NASDAQ: TVGN), a clinical-stage company specializing in immunotherapy, recently made headlines with its announcement of regained compliance with Nasdaq's listing standards. This pivotal moment for Tevogen showcases its dedication to maintaining a strong presence in the biotech...

Continue Reading
aTyr Pharma Investors: Join the Class Action Opportunity

Updated Category News Views 270

Understanding Your Rights as a Shareholder of aTyr Pharma Investors in aTyr Pharma, Inc. (NASDAQ: ATYR) are currently faced with a significant opportunity as a class action lawsuit has been initiated. This legal action is directed towards addressing serious concerns regarding the company's disclosures and conduct during a specific timeframe when many shareholders acquired...

Continue Reading
Chinafy and Lianwei Unite for Enhanced Web Solutions

Updated Category News Views 260

Chinafy and Lianwei Unveil Strategic Collaboration In an exciting development, Chinafy, a renowned cross-border web optimization platform, has announced a strategic partnership with Lianwei, a reputable provider of security and compliance consulting services. This collaboration marks the beginning of a new chapter in ensuring efficient web performance and regulatory...

Continue Reading
Insights on Octopus AIM VCT 2 plc's Current Net Asset Value

Updated Category News Views 107

Understanding the Current Net Asset Value of Octopus AIM VCT 2 plc Octopus AIM VCT 2 plc is a venture capital trust that has recently disclosed some important financial metrics regarding its net asset value (NAV). Knowing the NAV is crucial for investors as it represents the value of the company's assets minus liabilities, particularly helpful for assessing the worth of...

Continue Reading
FTAI Aviation: Unpacking Market Sentiment and Trends

Updated Category News Views 195

Understanding the Current Market Sentiment of FTAI Aviation In the realm of investments, the behavior of high-capital investors, often referred to as "whales," provides insightful indicators of market trends. Recently, these investors have taken a notably bearish stance on FTAI Aviation. Upon analyzing the options trading history for FTAI Aviation, there have been a total...

Continue Reading